Valneva SE Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Valneva SE Stock Summary

Valneva SE competes with NuCana PLC, Sage Therapeutic, Sellas Life, Third Harmonic, and Cullinan Oncology. Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on NASDAQ Exchange in the United States.

Valneva SE Key Financial Ratios

Valneva SE Key Balance Sheet Accounts

Valneva SE Key Income Statement Accounts

Valneva SE Key Cash Accounts

Valneva Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valneva SE competition to find correlations between indicators driving Valneva SE's intrinsic value. More Info.Valneva SE ADR is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . At this time, Valneva SE's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valneva SE's earnings, one of the primary drivers of an investment's value.

Valneva SE ADR Systematic Risk

Today, most investors in Valneva SE Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Valneva SE's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Valneva SE growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Valneva SE help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Valneva SE ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Valneva SE ADR based on widely used predictive technical indicators. In general, we focus on analyzing Valneva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Valneva SE's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.